Factors Associated With Death in Critically Ill Patients With Coronavirus Disease 2019 in the USShruti Gupta, Jean-Sébastien Rachoin, Salim S. Hayek et al.|JAMA Internal Medicine|2020Cited by 1k
COVID-19-associated acute kidney injury: consensus report of the 25th Acute Disease Quality Initiative (ADQI) WorkgroupMitra K. Nadim, John A. Kellum, Jay L. Koyner et al.|Nature Reviews Nephrology|2020Cited by 703
Association Between Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID-19Shruti Gupta, Sushrut S. Waikar, Wei Wang et al.|JAMA Internal Medicine|2020Cited by 555
Characteristics and Outcomes of Individuals With Pre-existing Kidney Disease and COVID-19 Admitted to Intensive Care Units in the United StatesJennifer E. Flythe, Samantha K. Brenner, Magdalene M. Assimon et al.|American Journal of Kidney Diseases|2020Cited by 234
Thrombosis, Bleeding, and the Observational Effect of Early Therapeutic Anticoagulation on Survival in Critically Ill Patients With COVID-19Hanny Al‐Samkari, Shruti Gupta, Wei Wang et al.|Annals of Internal Medicine|2021Cited by 140